phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

Medicare Part D provides prescription drug coverage for our nation’s seniors and Americans with disabilities. These beneficiaries can opt to enroll in Part D and pick from a variety of plans offered. Part D plans are private plans approved by the government that competitively bid against one another and negotiate with manufacturers to secure lower prices on medicines in the form of rebates and other discounts.

Here are three facts about the Part D program you may not know:

1. As a result of Part D, nearly 90% of Medicare beneficiaries have comprehensive drug coverage, amounting to more than 47 million beneficiaries in 2020. And since Part D’s inception, seniors enrolled in a Part D plan have experienced beneficial health outcomes, including an 8% decrease in hospital admissions, a 2.2% reduction in risk of mortality and an 18.3% decrease in non-emergency Emergency Department visits for seniors. In fact, more than 9 out of 10 Part D enrollees are satisfied with their coverage.

To ensure seniors and people with disabilities have access to treatments for serious and debilitating diseases, all Part D plans are required to cover “all or substantially all” medicines in six classes and categories. These six protected classes include anticonvulsants, antidepressants, antineoplastics, antipsychotics, antiretrovirals and immunosuppressants.

Part D Image 7

2. Part D beneficiaries have a variety of plans to choose from, ranging from 24 to 32 options in each state. Using the Medicare Plan Finder, beneficiaries are able to search and select the plan that works best for them during open enrollment. They can compare different plans to see which ones cover their prescription and what their out-of-pocket costs would be for the year. More than 80% of beneficiaries indicate that having a variety of plans to choose from is important to them.

040522_PhRMA_PartDBlog_G3

3. Medicare Part D drug spending, including brand medicines and generics, made up just under 11% of Medicare spending in 2019. Medicare Part D spending growth per enrollee has been stable over time, increasing just 0.3% between 2010 and 2015. One way Part D works to control costs for seniors is through the high utilization of lower-cost generics. Before Part D, seniors used generic medicines at low rates, with about 54% generic utilization in 2005. Since Part D’s launch, generic utilization has steadily increased to 87% in 2019 and, today, nearly nine out of ten Part D prescriptions filled with generics.

040522_PhRMA_PartDBlog_G1

While there are many things about Part D that have worked well, unfortunately more and more costs are being shifted to beneficiaries while at the same time plans are becoming more restrictive.

Learn more about the Part D program and stay tuned for tomorrow’s post that illustrates how the program could be improved for seniors and people with disabilities.

Gabby Migliara

Gabby Migliara is a director of Public Affairs at PhRMA focusing on internal communications and PhRMA’s digital presence, including maintaining this website and executive social presence. She previously worked with the U.S. Census Bureau on marketing and communications for the 2020 Census campaign. Outside the office, Gabby enjoys trying new restaurants, hanging with her cat and exploring D.C. neighborhoods.

What AARP isn’t telling seniors about MFN

August 24, 2026

CMS proposal could discourage patient-centered innovation

August 18, 2026

Nearly 1 in 4 patients initially denied access to IRA medicines

August 6, 2026

Medicare Part D at 20: Building on a strong foundation

July 23, 2026

Part D 101: Three charts show how the program provides comprehensive prescription drug coverage

Part D

Medicare

Part D 101: Three charts show how the program provides comprehensive prescription drug coverage

April 26, 2022

Part D 101: Three charts show how the program provides comprehensive prescription drug coverage

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list